Healthcare provider profile · identity verified

David Daniel, MD

Internal Medicine · BRONX, NY · NPI 1710143268

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Albuterol Sulfate	Albuterol Sulfate	252	35
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	241	30
Ipratropium Bromide	Ipratropium Bromide	236	13
Amlodipine Besylate	Amlodipine Besylate	199	52
Levetiracetam	Levetiracetam	170	35
Sodium Chloride	0.9 % Sodium Chloride	152	45
Atorvastatin Calcium	Atorvastatin Calcium	147	54
Gabapentin	Gabapentin	143	32
Furosemide	Furosemide	139	36
Levothyroxine Sodium	Levothyroxine Sodium	133	28
Metoprolol Tartrate	Metoprolol Tartrate	118	34
Silver Sulfadiazine	Silver Sulfadiazine	107	45
Famotidine	Famotidine	105	26
Latanoprost	Latanoprost	92	25
Sertraline Hcl	Sertraline Hcl	91	12
Hydralazine Hcl	Hydralazine Hcl	88	22
Tamsulosin Hcl	Tamsulosin Hcl	85	24
Piperacillin-Tazobactam	Piperacillin Sodium/Tazobactam	82	34
Budesonide	Budesonide	79	22
Eliquis	Apixaban	76	25
Metoprolol Succinate	Metoprolol Succinate	73	18
Omeprazole	Omeprazole	69	22
Lacosamide	Lacosamide	68	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	68	suppressed
Lisinopril	Lisinopril	62	suppressed
Metformin Hcl	Metformin Hcl	62	13
Midodrine Hcl	Midodrine Hcl	62	23
Ceftriaxone	Ceftriaxone Sodium	61	31
Carvedilol	Carvedilol	60	16
Pantoprazole Sodium	Pantoprazole Sodium	55	21
Escitalopram Oxalate	Escitalopram Oxalate	53	suppressed
Mirtazapine	Mirtazapine	53	19
Santyl	Collagenase Clostridium Hist.	51	22
Vancomycin Hcl	Vancomycin Hcl	51	21
Nystatin	Nystatin	49	20
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	47	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	47	suppressed
Losartan Potassium	Losartan Potassium	47	18
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	47	12
Oxycodone Hcl	Oxycodone Hcl	45	17
Ssd	Silver Sulfadiazine	45	18
Novolin N	Insulin Nph Human Isophane	44	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	42	suppressed
Phenytoin	Phenytoin	42	suppressed
Prednisone	Prednisone	41	17
Valproic Acid	Valproic Acid (As Sodium Salt)	40	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	39	16
Finasteride	Finasteride	36	suppressed
Januvia	Sitagliptin Phosphate	36	suppressed
Scopolamine	Scopolamine	36	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	34	11
Clopidogrel	Clopidogrel Bisulfate	33	suppressed
Xarelto	Rivaroxaban	33	suppressed
Potassium Chloride	Potassium Chloride	32	15
Ondansetron Hcl	Ondansetron Hcl	31	15
Amiodarone Hcl	Amiodarone Hcl	29	suppressed
Clonazepam	Clonazepam	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Atropine Sulfate	Atropine Sulfate	27	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	27	16
Dextrose In Water	Dextrose 5 % In Water	26	17
Lactulose	Lactulose	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Simvastatin	Simvastatin	26	suppressed
Methenamine Hippurate	Methenamine Hippurate	24	suppressed
Cefepime Hcl	Cefepime Hcl	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Baclofen	Baclofen	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Retacrit	Epoetin Alfa-Epbx	22	suppressed
Amoxicillin	Amoxicillin	21	suppressed
Divalproex Sodium	Divalproex Sodium	21	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	21	suppressed
Meropenem	Meropenem	21	12
Permethrin	Permethrin	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Myrbetriq	Mirabegron	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Daptomycin	Daptomycin	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	11
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	18	18
Alprazolam	Alprazolam	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Silodosin	Silodosin	17	suppressed
Combigan	Brimonidine Tartrate/Timolol	16	suppressed
Dextrose 5%-0.9% Nacl	Dextrose 5 % And 0.9 % Nacl	16	12
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	suppressed
Dextrose 5%-0.45% Nacl	Dextrose 5 %-0.45 % Sod Chlord	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	11
Novolin N Flexpen	Insulin Nph Human Isophane	15	suppressed
Rhopressa	Netarsudil Mesylate	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Allopurinol	Allopurinol	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Enulose	Lactulose	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	14	suppressed
Procrit	Epoetin Alfa	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Humulin N	Insulin Nph Human Isophane	13	suppressed
Nystop	Nystatin	13	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Avycaz	Ceftazidime/Avibactam	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed
Trazodone Hcl	Trazodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error